Influence of high-dose oral erythromycin on feeding intolerance in preterm neonates: A randomized controlled trial

Authors

  • Ali Mazouri Department of Pediatrics, Akbarabadi Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Maryam Saboute Department of Pediatrics, Akbarabadi Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Nasrin Khalesi Aliasghar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Zahra Farahani Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:

Background: Feeding intolerance is a common complication in preterm neonates and is responsible for prolonged hospitalization. This study aimed at assessing the effects of high-dose oral erythromycin on feeding intolerance in preterm infants.    Methods: A randomized, double blinded, placebo-controlled trial was performed during 2014 and 2015 (Tehran-Iran). Preterm neonates aged >14 days, who met the feeding intolerance criteria were selected for the study and their medical records were randomly assigned into 2 groups by simple randomization. Infants in group A received 10 mg/kg oral erythromycin every 6 hours for 2 days, followed by 4 mg/kg oral erythromycin every 6 hours for 5 days; and infants in group B received placebo with the same route. The number of days until reaching complete oral feeding, day of discharge from NICU, and complications related to intervention were recorded and compared between the 2 groups. Independent samples t test, Mann-Whitney, Fischer exact test, and Chi square were used to analyze the relationships between variables. P-value less than 0.05 was considered statistically significant.    Results: A total of 20 infants in group A received erythromycin and 20 infants in group B received placebo. Erythromycin could not alter the mean volume of feeding, duration of parental feeding, length of hospitalization, and frequency of feeding discontinuity (p>0.05); however, mean days to reach complete feeding in group A was significantly shorter than in group B (9.80 vs. 16.80 days; p=0.001).    Conclusion: High-dose erythromycin as a rescue measure with no potential adverse effect is beneficial in reducing the time taken to achieve full enteral feeding. However, more extensive investigations are needed to determine the best administration dosage.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Efficacy of high-dose oral erythromycin on enhancement of feeding tolerance in premature neonates

Objective: Most   neonates admitted to neonatal wards do not tolerate sufficient milk.  Recently the effect of erythromycin on increasing feeding tolerance in neonates has been studied. In this study the effectiveness of oral, high dose Erythromycin a prokinetic agent was used to enhance feeding tolerance in these neonates.  Methods: This prospective randomized controlled clinical trial was con...

full text

Effects of Metoclopramide on Feeding Intolerance among Preterm Neonates; A Randomized Controlled Trial

OBJECTIVE To evaluate the efficacy and safety of metoclopramide in the treatment of feeding intolerance in preterm neonates less than 36 weeks of gestational age. METHODS A randomized, controlled, masked cross-over study. A block of 4 randomizations was used. The "drug group" received intravenous metoclopramide before feeding and placebo group received placebo at the same time. The time to fu...

full text

Prophylactic oral probiotic on prevention of feeding intolerance in Very Low Birth Weight (VLBW) neonates: Randomized Clinical Trial

Background: Feeding intolerance is prevalent in very low birth weight (VLBW) neonates and is a barrier for better and faster growth in these neonates. Some studies have supported the administration of oral probiotic to decrease feeding intolerance. The aim of this study was to evaluate the effect of probiotic on feeding intolerance in VLBW neonates. Methods: This randomized clinical trial st...

full text

efficacy of high-dose oral erythromycin on enhancement of feeding tolerance in premature neonates

objective: most   neonates admitted to neonatal wards do not tolerate sufficient milk.  recently the effect of erythromycin on increasing feeding tolerance in neonates has been studied. in this study the effectiveness of oral, high dose erythromycin a prokinetic agent was used to enhance feeding tolerance in these neonates.  methods: this prospective randomized controlled clinical trial was con...

full text

Erythromycin for treatment of feeding intolerance in preterm infants.

OBJECTIVES To evaluate the effectiveness of high-dose erythromycin to treat feeding intolerance in preterm infants predominantly fed milk formula. DESIGN This study is a prospective randomized controlled trial on 60 premature infants suffering from feeding intolerance. Thirty infants were given oral erythromycin ethylsuccinate at a dose of 50 mg/kg/day for 10 days or until they reached full e...

full text

Comparison of intramuscular progesterone with oral nifedipine for treating threatened preterm labor: A randomized controlled trial

Background: Threatened preterm labor (TPL) is the leading cause of hospitalization during pregnancy. Tocolytic agents are the primary therapeutic options for TPL. The aim of this study is to compare intramuscular progesterone with oral nifedipine as a tocolytic agent. Methods: This randomized controlled trial was carried out in a teaching hospital (Shahid Akbarabadi) in Tehran, Iran, from De...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 32  issue 1

pages  47- 50

publication date 2018-02

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023